The impact of pharmacist telephone follow-up on control of type-2 diabetes

Evaluation of a Tele-Pharmacy Service to Improve Medication Adherence, Self-care activity, and Hb1Ac in Type 2 Diabetic Patients; A randomized Controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201212108612N1

Enrollment

106

Registered

2012-12-24

Start date

2012-12-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: Intervention Group: Patients attend a diabetes education workshop (4 hours). The educational content is designed by a diabetes educator pharmacist and an endocrinologist. PowerPoint pr

Intervention Group: Patients attend a diabetes education workshop (4 hours). The educational content is designed by a diabetes educator pharmacist and an endocrinologist. PowerPoint presentation will

Control Group: Patients attend the diabetes education workshop (4 hours). SMBG and logbook is provide for all the patients in this group. Test strips are also provided for the study period. The patie

Eligibility

Sex/Gender

All

Age

No minimum to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Type 2 diabetic patients using oral anti diabetic medications; age 7%; Adequate literacy and ability to use the glucometer; Adequate physical (hearing) and cognitive competence Exclusion Criteria: Patients requiring adjunct insulin therapy; Patients with concurrent heart failure (stage 4); Patients who fast in Ramadan

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Hemoglobin A1c. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: laboratory analysis.	—

Secondary

Measure	Time frame
Medication adherence. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: Morisky Medication Adherence Questionnaire.;Self-care activity. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: "Diabetes Self-care Activity Measure" questionnaire.;Total Cholestrol. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: laboratory analysis.;LDL. Timepoint: Change from baseline (at the point of recruiting) LDL level at 3 months. Method of measurement: Laboratory analysis.;HDL. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: Laboratory analysis.;Triglyceride. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: Laboratory analysis.	—

Measure

Time frame

Medication adherence. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: Morisky Medication Adherence Questionnaire.;Self-care activity. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: "Diabetes Self-care Activity Measure" questionnaire.;Total Cholestrol. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: laboratory analysis.;LDL. Timepoint: Change from baseline (at the point of recruiting) LDL level at 3 months. Method of measurement: Laboratory analysis.;HDL. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: Laboratory analysis.;Triglyceride. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: Laboratory analysis.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Sarayani

Research center for Rational Use of Drugs

a-sarayanib@razi.tums.ac.ir+98 21 8881 4157

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026